ProShare Advisors LLC Boosts Position in Mettler-Toledo International Inc. (NYSE:MTD)

ProShare Advisors LLC increased its position in shares of Mettler-Toledo International Inc. (NYSE:MTD - Free Report) by 7.5% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 4,265 shares of the medical instruments supplier's stock after purchasing an additional 299 shares during the quarter. ProShare Advisors LLC's holdings in Mettler-Toledo International were worth $5,219,000 at the end of the most recent quarter.

Other hedge funds have also recently added to or reduced their stakes in the company. JPMorgan Chase & Co. boosted its stake in shares of Mettler-Toledo International by 14.7% in the 3rd quarter. JPMorgan Chase & Co. now owns 221,799 shares of the medical instruments supplier's stock valued at $332,634,000 after purchasing an additional 28,478 shares during the last quarter. Allworth Financial LP raised its holdings in shares of Mettler-Toledo International by 367.4% in the fourth quarter. Allworth Financial LP now owns 215 shares of the medical instruments supplier's stock valued at $285,000 after purchasing an additional 169 shares during the last quarter. Robeco Institutional Asset Management B.V. lifted its position in shares of Mettler-Toledo International by 18.0% in the fourth quarter. Robeco Institutional Asset Management B.V. now owns 34,370 shares of the medical instruments supplier's stock worth $42,058,000 after purchasing an additional 5,234 shares in the last quarter. Tokio Marine Asset Management Co. Ltd. lifted its position in shares of Mettler-Toledo International by 773.3% in the fourth quarter. Tokio Marine Asset Management Co. Ltd. now owns 5,336 shares of the medical instruments supplier's stock worth $6,530,000 after purchasing an additional 4,725 shares in the last quarter. Finally, Impax Asset Management Group plc lifted its position in shares of Mettler-Toledo International by 5.8% in the fourth quarter. Impax Asset Management Group plc now owns 198,852 shares of the medical instruments supplier's stock worth $243,331,000 after purchasing an additional 10,830 shares in the last quarter. Institutional investors own 95.07% of the company's stock.

Analysts Set New Price Targets

A number of equities analysts recently weighed in on MTD shares. StockNews.com downgraded shares of Mettler-Toledo International from a "buy" rating to a "hold" rating in a report on Monday, May 5th. Citigroup upgraded shares of Mettler-Toledo International from a "neutral" rating to a "buy" rating and set a $1,400.00 target price on the stock in a report on Monday, April 7th. UBS Group upgraded shares of Mettler-Toledo International from a "neutral" rating to a "buy" rating and decreased their price objective for the company from $1,530.00 to $1,350.00 in a report on Tuesday. Jefferies Financial Group upgraded shares of Mettler-Toledo International from an "underperform" rating to a "hold" rating and decreased their price objective for the company from $1,200.00 to $1,110.00 in a report on Monday, May 5th. Finally, Wells Fargo & Company upped their price objective on shares of Mettler-Toledo International from $1,125.00 to $1,200.00 and gave the company an "equal weight" rating in a report on Monday, May 5th. Seven research analysts have rated the stock with a hold rating and four have given a buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of "Hold" and an average target price of $1,302.11.

Insider Transactions at Mettler-Toledo International

In related news, insider Christian Magloth sold 790 shares of the stock in a transaction on Monday, February 24th. The stock was sold at an average price of $1,313.69, for a total value of $1,037,815.10. Following the transaction, the insider now directly owns 734 shares in the company, valued at $964,248.46. This trade represents a 51.84% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Insiders own 0.77% of the company's stock.

Mettler-Toledo International Stock Performance

Shares of MTD stock traded down $53.29 on Wednesday, hitting $1,132.71. The company's stock had a trading volume of 405,689 shares, compared to its average volume of 149,042. Mettler-Toledo International Inc. has a fifty-two week low of $946.69 and a fifty-two week high of $1,546.93. The stock's 50 day moving average is $1,103.58 and its 200-day moving average is $1,215.53. The company has a market capitalization of $23.54 billion, a PE ratio of 27.95, a PEG ratio of 3.30 and a beta of 1.40.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last posted its earnings results on Thursday, May 1st. The medical instruments supplier reported $8.19 EPS for the quarter, topping analysts' consensus estimates of $7.90 by $0.29. The firm had revenue of $883.74 million during the quarter, compared to analysts' expectations of $876.61 million. Mettler-Toledo International had a net margin of 22.29% and a negative return on equity of 591.54%. The business's revenue for the quarter was down 4.6% compared to the same quarter last year. During the same quarter in the prior year, the business earned $8.89 earnings per share. On average, research analysts forecast that Mettler-Toledo International Inc. will post 42.71 earnings per share for the current year.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.